TD Cowen initiated coverage on Verona Pharma with a new price target
$VRNA
Biotechnology: Pharmaceutical Preparations
Health Care
TD Cowen initiated coverage of Verona Pharma with a rating of Buy and set a new price target of $100.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
4/28/2025 | $100.00 | Buy | TD Cowen |
4/21/2025 | $80.00 | Overweight | Cantor Fitzgerald |
1/10/2025 | $68.00 | Buy | ROTH MKM |
10/3/2024 | $50.00 | Overweight | Wells Fargo |
5/22/2023 | $35.00 → $38.00 | Buy | Jefferies |
9/19/2022 | $27.00 | Outperform | Wedbush |
8/26/2022 | $31.00 | Overweight | Piper Sandler |
11/12/2021 | $18.00 → $23.00 | Buy | Canaccord Genuity |